DENTAL AMALGAM MERCURY SOLUTIONS ........................... www.dams.cc
DAMS Intl. 1079 Summit Ave St Paul MN 55105 800-311-6265
Mercury causes
significant destruction of stomach and intestine epithelial cells, resulting in
damage to stomach lining which along
with mercury’s ability to bind to SH hydroxyl radical in cell membranes alters
permeability (338,405,35,21c,2) and adversely alters bacterial populations in
the intestines causing leaky gut syndrome with toxic, incompletely digested
complexes in the blood (116,228b,35,6) and accumulation of heliobacter
pylori, a suspected major factor in stomach ulcers and stomach cancer (256,6bc)
and Candida albicans, as well as poor nutrient
absorption (338,3).
Dental
amalgam has been found by thousands of medical lab tests and by medical studies
to be the largest
source of mercury exposure in most people who have several amalgam
fillings(7). Replacement of amalgam
fillings and metals detoxification have been found to significantly improve the
health of most with conditions related
to bowel dysfunction and leaky gut syndrome(8,9,303).
Other common causes or factors in leaky
gut and the related conditions include food allergies and intolerances; drugs(NSAIDs, aspirin, stomach h2
blockers, steroids,etc.); Dysbiosis(
overgrowth of harmful organisms due to antibiotic use and/or low probiotic levels); chronic alcohol consumption; toxic
exposures and chemical sensitivity; chronic infections; inadequate digestive
enzymes (6b)
While food allergies mediated by IgE can cause significant health effects including leaky
gut syndrome, these are usually easily identified by the immediateness of
reactions or skin tests. Food intolerances
mediated by IgG also commonly cause
significant health effects including leaky gut syndrome, but the reactions are
delayed and can be systemic and are harder to identify. Tests based on IgE such as skin test or RAST do not reliably identify such
problems that are common factors in chronic health conditions and tests such as
ELISA that measure both IgE and IgG
are more reliable. Common causes of food intolerances include failure to breast
feed babies for at least the first year of life, feeding table food in first
year of life, use of antibiotics without adequate addition of probiotics; eating the same foods every day(6b).
Food intolerances and food additives or processed foods that contain glutamate,
aspartame, high-fructose corn syrup, dyes, etc. are common causes of leaky gut
syndrome and neurological conditions such as ADHD(6b).
Food intolerances and IgG reactions lead to long lasting “immune complexes” that
are factors in leaky gut related conditions as well as conditions such as
Lupus, rheumatoid arthritis,
Similarly
food allergies or additives, food intolerances, high sugar consumption, and
antibiotic use with adequate probiotics have been found
to be the most common causes of children’s ear infections. Clinical studies
have found that diets high in flavanoids, cartenoids, and including nutritional supplements such as buffered
Vit C and natural E, selenium, omega-3 oils, probiotics are effective in preventing ear infections and
other chronic conditions(6b). These in addition to
multiple B vitamins, the flavanoids curcumin, hesperidin, and quercetin are effective in preventing and treating leaky
gut related conditions(6,480).
Crohn’s
disease usually occurs at a relatively young age and results when an immune or
autoimmune response causes increased inflammatory cytokines like TNFa, IL-6, and IL-1b, resulting in inflammation of the
ileum or colon(480). This usually results in thinning
of the bowel wall and often formation of ulcers on the intestinal lining.
Functional neutrophil deficiencies are often a factor
in Crohn’s disease.
In addition to improvements in many patients after amalgam replacement
and detoxification, diet and nutritional measures are usually effective at
improving Crohn’s Disease(580). The 4-R program has seen good success in many
patients. The program removes all foods
where there is suspicion of allergy that might produce inflammation. Common allergen’s include wheat/gluten, dairy, eggs, peanuts, tomatoes,
corn, and red meat. Additionally elimination
of gastrointestinal parasites, undesirable bacteria, fungus, and yeasts are
carried out. Sometimes a treatment such as nystantin
is used to eliminate yeast.(480). Then vital nutrients
are
replaced by dietary measures and supplementation of a good multivitamin and
mineral, minerals found deficient such as iron,
magnesium, calcium, selenium, zinc, iodine and vitamins such as B-complex, B6,
B12, folic acid. Next the intestines are reinocculated
with friendly bacteria(Lactobacillus acidophilus and Lactobacilus bulgaricus. Finally
measures are taken to repair the intestine to correct for thee increased
permeability. This is done by adding nutrients such as glutamine, pathothenic acid (B5), zinc, FOS, and vitamin C. DHEA and
Butyrate have also been found effective in many patients at reducing inflammation(480).
Supplements and other treatments that reduce
intestinal permeability have also been found to be protective against and to improve
these conditions. Glutamine, berberine, probiotics, and vitamin D have been found to decrease
intestinal permeability and protect against effects caused by leaky gut syndrome(4,5,480,487). Butyrate has been found to inhibit
inflammation and carcinogenesis in the intestines and low butyrate levels are
found in colon cancer, ulcerative colitis, and Crohn’s
disease(10). Butyrate and phosphatidylcholine
have been found to be protective against these conditions, and increased fiber
content in diet promotes increased butyrate levels, through the effect on
fermentation pattern(10).
Brain inflammation or hypoglycemia
related to toxic metal exposures, food intolerances, etc. have been found to be
common causes of ADHD, impulsivity, juvenile delinquency, criminality, and violence
(6b,11,115).Detoxification, diet measures, and supplementation for deficient
vitamins and minerals have been found to usually improve such conditions.
References:
(4) Intestinal permeability
and systemic infections in critically ill patients, effect of glutamine, Crit Care Med. 2005 May, 33(5):1175-8; & (b)Protective effect of glutamine on
intestinal barrier function in patients receiving chemotherapy, Zhonghua Wei Chang Wai Ke Za
Zhi 2006, Jan, 9(1):59-61, Jiang
H P, Liu CA; & (c) Berberine inhibits ion
transport in human colonic epithelia, Eur J Pharmocol, 1999, Feb 26;
368(1):111-8.
(6) (a)
Hidden Causes of GI Dysfunction, C.D. Meletis, Vitamin
Research News, vol 22, no.4,
April
2008; & (b) Are You the Victim of Hidden Allergies?, The Blaylock Wellness
Report,
Vol 4, No. 11, Nov 2007; & (c) Food Additives:
What You Eat Can Kill You, The Blaylock Wellness Report, Vo. 4, No. 10, Oct 2007 www.blaylockreport.com
&
(d) www.flcv.com/autismgc.html;
&(e) www.flcv.com/diabetes.html; & (f) www.flcv.com/kidshg.html
(7) Mercury exposure levels from dental
amalgam, medical lab tests and medical studies, B. Windham (Ed), 2007, www.flcv.com/damspr1.html
(8) Documentation of recovery
of significant improvement in over 30 chronic health conditions after amalgam
replacement, peer-reviewed
studies and clinical studies, www.flcv.com/hgremove.html
(9) Percentage with
significant health improvement after dental amalgam replacement by chronic
condition, FDA
reports and clinical case reports, www.flcv.com/hgrecovp.html
10(a) The
role of butyrate on colonic function, Aliment Pharmocol
Ther, 2008 Jan 15:27(2):104-119, Hamer
HM, Jonkers, d et al; & (b) Dietary modulation of
colon cancer risk, J Nutr 2007, Nov 137(11 Suppl):2576S-2579S, Kim YS, Milner JA; & (c) Mucosal
metabolism in ulcerative colitis and Crohn’s Disease,
Dis Colon Rectum, 1998, Nov: 41(11):1399-1405; &
(d) Down-regulation of the onocarboxylate transporter
1 is involved in butyrate deficiency during intestinal inflammation, Gastroenterology, 2007, Dec 133(6):1916-27;
& (e) Influence of dietary fiber on inflammatory bowel disease and colon
cancer: importance of fermentation pattern, Nutr Rv. 2007 Feb,65(2):51-62; & (f) Effect of
polyunsaturated fatty acid-enriched phosphatidylcholine
and phosphatidylserine on butyrate-induced growth
inhibition, differentiation, and apoptosis in Caco-2 cells, Cell Bichem Funct 2006 Mar-Apr,
24(2):159-65; & (g)Oral butyrate for mildly to moderately active Crohn's disease,
& Di Sabatino
A, Morera R, Corazza GR. Et al, Aliment Pharmacol Ther. 2005 Nov 1;22(9):789-94
(11) Toxic metal exposures
common factors in ADHD, violence, impulsivity, juvenile delinquency, and
criminality; B.Windham (Ed), www.flcv.com/violence.html
(20)
(21) R.A.Goyer,”Toxic
effects of metals”in: Caserett
and Doull’s Toxicology- TheBasic
Science of Poisons, McGraw-Hill Inc., N.Y., 1993; &(b) Goodman,
Gillman, The Pharmacological Basis of Therapeutics, Mac Millan
Publishing Company, N.Y. 1985; &(c) Encyclopedia of Occumpational
Health and Safety, International Labour Office,
Geneva, Vol 2, 3rd Edition.
(33) (a) Markovich et
al, "Heavy metals (Hg,Cd) inhibit the
activity of the liver and kidney sulfate transporter Sat‑1",
Toxicol Appl
Pharmacol, 1999,154(2):181‑7;
& (b)2S.A.McFadden, “Xenobiotic metabolism and
adverse environmental response: sulfur-dependent detox
pathways”,Toxicology, 1996, 111(1-3):43-65;
&(c) Alberti
A, Pirrone P, Elia M, Waring RH, Romano C.
Sulphation deficit in “low-functioning” autistic children. Biol
Psychiatry 1999, 46(3):420-4.
(35) (a)Levy T.E., Huggins HA,
Uniformed Consent: the hidden dangers in dental care, 1999,
Hampton Roads Publishing Company Inc;
(43) (a)Knapp LT; Klann E. Superoxide‑induced
stimulation of protein kinase C via thiol
modification and modulation of zinc content. J Biol Chem 2000 May 22; &(b) B.Rajanna et al, “Modulation of protein kinase
C by heavy metals”, Toxicol Lett, 1995,
81(2-3):197-203: & A.Badou et al, “HgCl2-induced
IL-4 gene expression in T cells involves a protein kinase
C-dependent calcium influx through L-type calcium channels”J
Biol Chem. 1997 Dec 19;272(51):32411-8., & D.B.Veprintsev,
1996, Institute for Biological Instrumentation, Russian Academy of
Sciences, Pb2+ and Hg2+ binding to alpha‑lactalbumin”.Biochem Mol Biol Int
1996 Aug;39(6):1255‑65
(51) Heintze et al,“Methylation
of Mercury from dental amalgam and
mercuric chloride by oral Streptococci”.,Scan.
J. Dent. Res. 1983, 91:150‑152: & Wang J, Liu Z; [.In vitro Study of Strepcoccus Mutans in the Plaque
on the Surface of Amalgam Fillings on the Conversion of Inorganic Mercury to
Organic Mercury][Article in Chinese], Shanghai Kou Qiang
Yi Xue. 2000 Jun;9(2):70-2;
& L.I.Liang et al, "Mercury reactions in the
human mouth with dental amalgams" Water, Air, and Soil pollution,
80:103-107; & (b) Rowland, Grasso, Davies “The Methylation of Mercuric
Chloride by Human Intestinal Bacteria”. Experientia. Basel 1975 ,31: 1064‑1065; & M.K.Hamdy et al, “Formation of methyl mercury by bacteria”,
App Microbiol, 1975, Sept.; & Ludwicki
JK Studies on the role of gastrointestinal tract contents in the methylation of inorganic mercury compounds Bull Env Contam Toxicol 42 1989
283-288; & (c) Choi SC, Bartha R.. Cobalamin-mediated mercury methylation by Desulfovibrio desulfuricans LS. Appl Environ Microbiol. 1993 Jan;59(1):290-5;
(54) M.E.
Lund et al, “Treatment of acute MeHg poisoning by
NAC”, J Toxicol Clin Toxicol, 1984, 22(1):31-49; & Livardjani F; Ledig M; Kopp P; Dahlet M; Leroy
M; Jaeger A. Lung and blood superoxide dismustase activity in
mercury vapor exposed rats: effect of N‑acetylcysteine
treatment. Toxicology 1991 Mar 11;66(3):289‑95
(96)
Goyer RA, National Institute of Environmental
Health Sciences. Toxic
and essential metal interactions.
Annu Rev Nutr 1997;
(111) (a) Quig
D, Doctors Data Lab,"Cysteine metabolism and metal toxicity", Altern
Med Rev, 1998;3:4, p262‑270, &
(b) J.de Ceaurriz et al,
Role of gamma‑ glutamyltraspeptidase(
"Renal
glutathione and
mercury uptake", Fundam Appl Toxicol, 1985,
5(5):832‑9; & Zalups RK, Barfuss DW. Accumulation and handling of inorganic
mercury in the kidney after coadministration with
glutathione, J
Toxicol
Environ Health, 1995, 44(4): 385-99; &
T.W.Clarkson et al, "Billiary
secretion of glutathione‑metal complexes", Fundam Appl Toxicol, 1985,
5(5):816‑31;
(115) (a) Biochemical
Treatment of Mental Illness and Behavior Disorders, William
J. Walsh, Ph.D. Health Research Institute, Minnesota Brain Bio Association November 17, 1997 http://www.hriptc.org/BioTreatment.html ; &(b) Walsh WJ, Isaacson Hr, Hall A,
Elevated blood copper to zinc ratios in assaultive
young males, Physiol Behav.
1997 Aug;62(2):327-9;
(116)
Liebert CA; Wireman J; Smith T; Summers AO, "The
impact of mercury released from dental "silver" fillings on
antibiotic resistance in the primate oral and intestinal bacterial flora",
Met Ions Biol Syst 1997;34:441-60; & (b) A.O.Summers et al, Antimicrobial Agents and Chemotherapy,
37(4):825-834,1993; &(c) Mercury resistance among clinical isolates of
Escherichia coli. Poiata
A, Badicut I, Indres M, Biro M, Buiuc D. Roum
Arch Microbiol Immunol.
2000 Jan-Jun;59(1-2):71-9; & (d) Resistance of the normal human microflora to mercury and antimicrobials after exposure to
mercury from dental amalgam fillings. Edlund C, Bjorkman L, Ekstrand J, Sandborgh-Englund G,
Nord CE.
Clin Infect Dis. 1996 Jun;22(6):944-50; & (e) M.Vimy et al,” Silver dental fillings provoke an
increase in mercury and antibiotic resistant bacteria in the
mouth and intestines of primates”,
APUA Newsletter, Fall, 1991.
(126)(a)Singh I, Pahan K, Khan M,
(181) P.W.
Mathieson, “Mercury: god of TH2 cells”,1995, Clinical Exp Immunol.,102(2):229-30; & (b)
(194)
(225) S.
Yannai et al, “Transformations of inorganic mercury
by candida albicans and
Saccharomyces cerevisiae”,
Applied Envir Microbiology,1991, 7:245-247; & N.E.Zorn et al, “ A relationship between Vit B-12, mercury uptake, and methylation”,
Life Sci, 1990, 47(2):167-73; & Ridley WP, Dizikes
L, Cheh A, Wood JM.
Recent studies on biomethylation and demethylation of toxic elements. Environ Health Perspect 1977 Aug;19:43‑6 & R.E.DeSimone
et al, Biochem Biophys Acta, 1973,May 28; & Yamada, Tonomura“Formation of methyl Mercury
Compounds from inorganic Mercury by
Clostridium cochlearium” J Ferment Technol1972
50:159‑1660
(228) (a)A.F.Zamm, “Removal of dental mercury: often an effective treatment for very sensitive patients”, J Orthomolecular Med, 1990, 5(53):138-142. (22 patients); & (b)Dr. T. Rau, Paracelsus Alergy Clinic, Lustmuhle, Switzerland, Allergies: Causes, Clarification, Treatment; Explore, 8(4),1996, www.explorepub.com/articles/bio‑therapy.html ; & (c) Dr. B. Shelton, Director, The Allergy Center, Phoenix, Arizona, www.hamptonroadspub.com/main/books/excerpts/elements2.html; & (d) E. Cutler, Winning the War against Asthma & Allergies, Delmar Learning; 1st edition (July 9, 1997)
(252) B.J.Shenker et al, Dept. of Pathology,
(256) D.B.Alymbaevaet al, Med Tr Prom Ekol,
(285) R.C.Perlingeiro et al, “Polymorphonuclear
phagentosis in workers exposed to mercury vapor”, Int
J Immounopharmacology”, 16(12):1011-7,1994; & Hum
Exp Toxicol 1995, 14(3):281-6; &
M.L. Queiroz et al, Pharmacol Toxicol, 1994,
74(2):72-5; & (b) J.W.Albers et al, “Neurological
abnormalities associated with remote occupational elemental mercury exposure”,Ann Neurol 1988,
24(5):651-9
(303) Heavy Metals and Chronic Diseases , Dr.
Dietrich Klinghardt, M.D., PhD, http://www.neuraltherapy.com/a_metals_disease.asp
(314) M.Kubicka-Muranyi
et al, “Systemic autoimmune disease induced by mercuric chloride”, Int Arch Allergy Immunol;1996, 109(1):11-20; & M.Goldman et al,1991,“Chemically induced autoimmunity
...”,Immunology Today,12:223-; & K. Warfyinge et
al, “Systemic autoimmunity due to mercury vapor exposure in genetically
susceptible mice”, Toxicol Appl Pharmacol, 1995,
132(2):299-309;& L.M. Bagenstose et al, “Mercury
induced autoimmunity in humans”, Immunol Res, 1999,20(1): 67-78
(338) (a)W.Y.Boadi et al, Dept. Of Food Engineering and
Biotechnology, T-I Inst of Tech., Haifa, Israel, “In vitro effect of mercury
on enzyme activities and its accumulation in the first-trimester human placenta”, Environ Res,
1992, 57(1):96-106;& “In vitro exposure to mercury and cadmium alters term
human placental membrane fluidity”, Pharmacol, 1992, 116(1): 17-23; & (b)J.Urbach
et al, Dept. of Obstetrics & Gynecology, Rambam
Medical Center, Haifa, Israel, “Effect of inorganic mercury on in vitro placental nutrient transfer and oxygen
consumption”, Reprod Toxicol, 1992,6(1):69-75;&
© Karp W, Gale TF et al, Effect of
mercuric acetate on selected enzymes of maternal and fetal hamsters”
Environmental Research, 36:351-358; &
W.B. Karp et al, “Correlation of human placental enzymatic activity with trace metal concentration in placenta”, Environ Res. 13:470- 477,1977; & (d) Boot JH.
Effects of SH‑blocking compounds on the energy metabolism and
glucose uptake in isolated rat hepatocytes. Cell Struct Funct 1995 Jun;20(3):233‑8;
& Semczuk
M, Semczuk‑Sikora A. New data on toxic metal intoxication (Cd, Pb, and Hg in particular) and Mg status
during pregnancy. Med Sci Monit 2001 Mar;7(2):332‑340; & (e) H.Iioka
et al, “The effect of inorganic mercury on placental amino acid transport”,
(369) Sterzl
I, Prochazkova J, Stejskal
VDM et al, Mercury and nickel allergy: risk factors in fatigue and
autoimmunity. Neuroendocrinology Letters
1999; 20:221-228; & Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VD; The beneficial effect of amalgam
replacement on health in patients with autoimmunity. Neuro Endocrinol
Lett. 2004 Jun;25(3):211-8. http://www.melisa.org/pdf/Mercury-and-autoimmunity.pdf
(404) M. E. Godfrey, Candida, Dysbiosis
and Amalgam. J.
Adv. Med. vol 9 no 2 (1996); & Romani L, Immunity to Candida Albicans:
Th1,Th2 cells and beyond. Curr Opin Microbiol
1999, 2(4):363-7; & Alfred V. Zamm. CANDIDA
ALBICANS THERAPY: Dental mercury removal, an effective adjunct. J. Orthmol. Med. v1#4 pp261-5 (1986)
(469) M.M. van Benschoten,
““Acupoint Energetics of
Mercury Toxicity and Amalgam Removal with Case Studies,”” American Journal of
Acupuncture, Vol. 22, No. 3, 1994, pp. 251-262; & M.M. Van Benschoten and Associates, Reseda, Calif. Clinic; http://www.mmvbs.com/
(470) Dr. Garth Nicholson, Institute for
Molecular Medicine,
(405) Stejskal J, Stejskal V.
The role of metals in autoimmune diseases and the link to neuroendocrinology Neuroendocrinology
Letters, 20:345‑358, 1999.
www.melisa.org/
(410) J.R. Cade
et al, Autism and schizophrenia linked to malfunctioning
enzyme for milk protein digestion. Autism, Mar
1999.
(411) Puschel
G, Mentlein R, Heymann E,
'Isolation and characterization of dipeptyl peptidase
IV from human placenta', Eur J Biochem
1982 Aug;126(2):359-65; &
(412) (a) Moreno-Fuenmayor
H, Borjas L, Arrieta A, Valera V, Plasma
excitatory amino acids in autism. Invest
Clin 1996,37(2):113-28;&
Carlsson ML. Is infantile autsim
a hypoglutamatergic disorer? J Neural Transm 1998, 105(4-5): 525-35. & (b)Rolf LH,
Haarman FY, Grotemeyer KH, Kehrer H. Serotonin
and amino acid content in platelets
of autistic children. Acta Psychiatr Scand 1993, 87(5):
312-6; &
(c)Naruse H, Hayashi
T,
Takesada M, Yamazaki K. Metabolic changes in aromatic amino acids and
monoamines in
infantile autism and a new related treatment, No
To Hattatsu, 1989, 21(2):181-9;
(479) Amphotericin
B, HgCl2 and Peritoneal Transport in Rabbits,
Zweers MM, Douma CE,
van der Wardt AB,
Krediet RT, Struijk DG.
Department of Nephrology,
(480) Life Enhancement Foundation
(MDs), Disease Treatment and Prevention, Expanded 4th Edition, 2003.
(481) Vitamin Research News, studies
in various volumes, see achieve, www.vrp.com
(485) Dr. Hulda
Clark, The Cure for all Diseases, New Century Press,2000,
www.drclark.net (amalgam replacement and treatment for parasites/bacteria)(U.S.
CDC confirms parasites common in those with chronic immune conditions) &
U.S. Center for Disease Control, Parasites(widespread exposures), www.dpd.cdc.gov/dpdx/HTML/Para_Health.htm
;www.cdc.gov/ncidod/diseases/list_parasites.htm
(487) Vitamin
Research News, Vol 23, No. 1, Jan 2009,
Gastrointestinal Support, p12-17.
(506) Leistevuo J, Pyy L, Osterblad M, Dental amalgam fillings and the amount of
organic mercury in human saliva. Caries Res 2001 May‑Jun;35(3):163‑6; & Leistevuo J et al., Dental amalgam fillings
and the amount of organic mercury in human saliva, Corks Res,
35(3):163-6 (2001 May-Jun)